Angiogenesis in cancer, vascular, rheumatoid and other disease
about
Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesisTetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesisNanotechnology-mediated targeting of tumor angiogenesisOverexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesisEDF-1, a novel gene product down-regulated in human endothelial cell differentiationCloning of a unique lipase from endothelial cells extends the lipase gene familyPlacenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesisTungsten carbide-cobalt nanoparticles induce reactive oxygen species, AKT, ERK, AP-1, NF-kB, VEGF, and angiogenesisAngiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formationIsolation and characterization of the human gene homologous to the Drosophila headcase (hdc) gene in chromosome bands 6q23-q24, a region of common deletion in human pancreatic cancerA fragment of human TrpRS as a potent antagonist of ocular angiogenesis.Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesisThe endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cellsRegulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrinsCCN3 (NOV) is a novel angiogenic regulator of the CCN protein familyAngiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinomaThe anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent mannerA novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptorsVasohibin as an endothelium-derived negative feedback regulator of angiogenesisProtein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesisAngiomotin regulates endothelial cell-cell junctions and cell motilityGenomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoformVascular endothelial growth factor B, a novel growth factor for endothelial cellsAstrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesisNew role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survivalA novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinasesThe potential role of amyloid beta in the pathogenesis of age-related macular degeneration.VEGF-Trap: a VEGF blocker with potent antitumor effects.Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.Interaction of endostatin with integrins implicated in angiogenesisA DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growthFisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivoNG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrinVascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor modelEdg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturationThe tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinThe anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidaseCYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth
P2860
Q21090869-482BBA55-3B44-472C-B29D-9E7D6E36F3A9Q21142634-0E7BC864-F6FA-4795-861A-F98AA39CC738Q21195857-25725864-CEF2-40BE-9941-E2B52697EA76Q21245720-0962081C-9CE7-42C8-AB7A-049C0873BC5AQ22007989-04E3843C-C42B-489C-9764-34F252E26C29Q22009533-5FBBD6E8-53A7-4FEE-BCBC-2B0C87685567Q22010852-78D418DE-6F6D-4ED6-93ED-29FA46BFA0C1Q23917016-B56E2607-5803-4101-A1DE-320F0BA6A628Q24290939-9C25B8C8-AAE7-465E-B267-970AC73EF5C2Q24291876-06A4559C-BFDF-4A3F-B030-3AD1BCBF2B32Q24292091-2ACE8D55-000D-490B-BCF5-F531BB07A7FCQ24295251-359879C5-AB98-4124-940D-0B23E81936CEQ24295296-257C6C46-C7EB-47EB-B412-3CE54C51D204Q24298525-7E0CD04D-760A-4F18-BAF4-C2A9E2013B5FQ24299560-88377A38-B2B0-4933-94C0-252E616793ADQ24299868-178454B1-D518-4DDA-AC3D-4AEA52FF5A5BQ24300294-2C60CFF8-CEB4-4B89-ABA3-9142B3BF7D8AQ24302060-18948520-CECE-40A8-A49E-4A06A17B7438Q24305065-F0F3FC1B-3C6E-4DA3-B136-AD1DBC3A38D1Q24306415-716D0CF7-358B-4138-B5CF-FF5B52385B8AQ24309609-66C8E02C-B0C6-4D20-9B60-570C47A7D285Q24310005-3F4FE19D-A9CC-43E6-ABC1-5FD9126326E3Q24311517-6166ADF9-9A4C-4E9E-A00D-CCFC31B75E67Q24312842-29370592-EC07-41DB-8133-E122E74AF1D0Q24321673-C120B597-91D6-4252-BC31-2CED162D7C31Q24336075-593F98FF-0AE1-44BD-A1CD-F5BA7ABE3014Q24336293-96F98A01-844F-4959-AC27-C4439C5E0C29Q24532130-D58620C0-2792-4372-967B-6915DB541E4DQ24535043-F006C1EC-771C-45AA-96C4-E6881CEE0962Q24540447-0AAF8EC5-BE4B-4C86-AA32-3353CF89E41DQ24545535-CEACC0D0-9EC9-44C8-80F6-40C5322BAA4FQ24548511-8B71BFB7-7D61-45E7-9E74-81C473A5F19BQ24554513-1ADDD87B-7117-4455-9CDB-1919BCA6BF76Q24561606-07390DCF-AD0E-46B9-ABA6-387185FB09F0Q24568018-CFB0D418-46FD-4B8A-A7A8-8397030209CFQ24612339-77C884D4-5EBD-4457-9E9C-3F40D851E778Q24629370-462DF9E3-BD08-4DE2-AD1D-E261642306CDQ24633116-0AC3DF82-7C6D-4D2C-808D-FDBB874AF021Q24646329-E1469E89-4124-4475-A179-91965E76EACBQ24647068-5085F93A-DF50-4A2B-9AA7-1F7BEE0E74D8
P2860
Angiogenesis in cancer, vascular, rheumatoid and other disease
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Angiogenesis in cancer, vascular, rheumatoid and other disease
@ast
Angiogenesis in cancer, vascular, rheumatoid and other disease
@en
type
label
Angiogenesis in cancer, vascular, rheumatoid and other disease
@ast
Angiogenesis in cancer, vascular, rheumatoid and other disease
@en
prefLabel
Angiogenesis in cancer, vascular, rheumatoid and other disease
@ast
Angiogenesis in cancer, vascular, rheumatoid and other disease
@en
P3181
P356
P1433
P1476
Angiogenesis in cancer, vascular, rheumatoid and other disease
@en
P2093
P2860
P2888
P3181
P356
10.1038/NM0195-27
P407
P577
1995-01-01T00:00:00Z
P6179
1008981922